Blake Gurfein
Chief Tech/Sci/R&D Officer bij TIVIC HEALTH SYSTEMS, INC.
Vermogen: 1 400 $ op 31-03-2024
Profiel
Blake Gurfein is currently the Chief Scientific Officer at Tivic Health Systems, Inc. He previously held the same position at Rio Grande Neurosciences, Inc. from 2014 to 2017.
Gurfein received his undergraduate degree from Brown University and his doctorate from Icahn School of Medicine at Mount Sinai.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-03-2024 | 1 120 ( 0.08% ) | 1 400 $ | 31-03-2024 |
Actieve functies van Blake Gurfein
| Bedrijven | Functie | Begin |
|---|---|---|
| TIVIC HEALTH SYSTEMS, INC. | Chief Tech/Sci/R&D Officer | 01-03-2019 |
Eerdere bekende functies van Blake Gurfein
| Bedrijven | Functie | Einde |
|---|---|---|
Rio Grande Neurosciences, Inc.
 Rio Grande Neurosciences, Inc. Hospital/Nursing ManagementHealth Services Rio Grande Neurosciences, Inc. offers neurological and psychiatric therapies. It focuses on developing, acquiring, and licensing non-invasive brain stimulation therapies used to treat pathologies of the central nervous system. The company was founded in 2011 and is headquartered in Santa Fe, NM. | Chief Tech/Sci/R&D Officer | 01-01-2017 |
Opleiding van Blake Gurfein
| Brown University | Undergraduate Degree |
| Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TIVIC HEALTH SYSTEMS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Rio Grande Neurosciences, Inc.
Rio Grande Neurosciences, Inc. Hospital/Nursing ManagementHealth Services Rio Grande Neurosciences, Inc. offers neurological and psychiatric therapies. It focuses on developing, acquiring, and licensing non-invasive brain stimulation therapies used to treat pathologies of the central nervous system. The company was founded in 2011 and is headquartered in Santa Fe, NM. | Health Services |
